{"id":"https://openalex.org/W2892536249","doi":"https://doi.org/10.1093/ofid/ofy210.557","title":"549. Weight and BMI Changes in HIV-Infected Virologically Suppressed Adults after Switching to an Elvitegravir- or Dolutegravir-Containing Regimen","display_name":"549. Weight and BMI Changes in HIV-Infected Virologically Suppressed Adults after Switching to an Elvitegravir- or Dolutegravir-Containing Regimen","publication_year":2018,"publication_date":"2018-11-01","ids":{"openalex":"https://openalex.org/W2892536249","doi":"https://doi.org/10.1093/ofid/ofy210.557","mag":"2892536249"},"language":"en","primary_location":{"id":"doi:10.1093/ofid/ofy210.557","doi":"https://doi.org/10.1093/ofid/ofy210.557","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ofid/ofy210.557","pdf_url":null,"source":{"id":"https://openalex.org/S2735126445","display_name":"Open Forum Infectious Diseases","issn_l":"2328-8957","issn":["2328-8957"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infectious Diseases","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1093/ofid/ofy210.557","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Amanda Gibson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]},{"id":"https://openalex.org/I4210148268","display_name":"University of Utah Health Care","ror":"https://ror.org/047s7ex42","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210148268"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amanda Gibson","raw_affiliation_strings":["University of Utah Health, Salt Lake City, Utah"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Utah Health, Salt Lake City, Utah","institution_ids":["https://openalex.org/I223532165","https://openalex.org/I4210148268"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036762753","display_name":"Adam M. Spivak","orcid":"https://orcid.org/0000-0003-1815-7893","observed_orcids":["https://orcid.org/0000-0003-1815-7893"]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Adam Spivak","raw_affiliation_strings":["Department of Internal Medicine, Division of Infectious Diseases, University of Utah School of Medicine, Salt Lake City, Utah"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, Division of Infectious Diseases, University of Utah School of Medicine, Salt Lake City, Utah","institution_ids":["https://openalex.org/I223532165"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061198124","display_name":"Angela P. Presson","orcid":"https://orcid.org/0000-0001-7400-3923","observed_orcids":["https://orcid.org/0000-0001-7400-3923"]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Angela Presson","raw_affiliation_strings":["Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah","institution_ids":["https://openalex.org/I223532165"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5070982846","display_name":"Christine Jamjian","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]},{"id":"https://openalex.org/I4210148268","display_name":"University of Utah Health Care","ror":"https://ror.org/047s7ex42","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210148268"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christine Jamjian","raw_affiliation_strings":["University of Utah Health, Salt Lake City, Utah"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Utah Health, Salt Lake City, Utah","institution_ids":["https://openalex.org/I223532165","https://openalex.org/I4210148268"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4053,"currency":"USD","value_usd":4053},"apc_paid":{"value":4053,"currency":"USD","value_usd":4053},"fwci":null,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"5","issue":"suppl_1","first_page":"S204","last_page":"S204"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11655","display_name":"HIV-related health complications and treatments","score":0.9214000105857849,"subfield":{"id":"https://openalex.org/subfields/2711","display_name":"Emergency Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11655","display_name":"HIV-related health complications and treatments","score":0.9214000105857849,"subfield":{"id":"https://openalex.org/subfields/2711","display_name":"Emergency Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.07519999891519547,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.002300000051036477,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/weight-gain","display_name":"weight gain","score":0.9340000152587891},{"id":"https://openalex.org/keywords/body-mass-index","display_name":"body mass index","score":0.9660000205039978},{"id":"https://openalex.org/keywords/elvitegravir","display_name":"elvitegravir","score":0.9100000262260437},{"id":"https://openalex.org/keywords/dolutegravir","display_name":"dolutegravir","score":1.0},{"id":"https://openalex.org/keywords/integrase-strand-transfer-inhibitors","display_name":"integrase strand transfer inhibitors","score":0.9909999966621399},{"id":"https://openalex.org/keywords/antiretroviral-therapy-switching","display_name":"antiretroviral therapy switching","score":0.9380000233650208},{"id":"https://openalex.org/keywords/virologically-suppressed-patients","display_name":"virologically suppressed patients","score":0.8859999775886536},{"id":"https://openalex.org/keywords/drug-induced-weight-gain","display_name":"drug-induced weight gain","score":0.6349999904632568},{"id":"https://openalex.org/keywords/diabetes-risk","display_name":"diabetes risk","score":0.6380000114440918},{"id":"https://openalex.org/keywords/cardiovascular-risk","display_name":"cardiovascular risk","score":0.8460000157356262},{"id":"https://openalex.org/keywords/hiv-associated-lipodystrophy","display_name":"HIV-associated lipodystrophy","score":0.5690000057220459},{"id":"https://openalex.org/keywords/hiv-associated-lipoatrophy","display_name":"HIV-associated lipoatrophy","score":0.6190000176429749}],"concepts":[{"id":"https://openalex.org/C2779502633","wikidata":"https://www.wikidata.org/wiki/Q937224","display_name":"Dolutegravir","level":5,"score":0.965753972530365},{"id":"https://openalex.org/C2777068322","wikidata":"https://www.wikidata.org/wiki/Q2740966","display_name":"Elvitegravir","level":5,"score":0.9576489329338074},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8820749521255493},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.8250998854637146},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.47771787643432617},{"id":"https://openalex.org/C2777302000","wikidata":"https://www.wikidata.org/wiki/Q412251","display_name":"Integrase inhibitor","level":5,"score":0.45728251338005066},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4468202292919159},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.4190281629562378},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.21702882647514343},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.18191233277320862},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.13468465209007263},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1093/ofid/ofy210.557","doi":"https://doi.org/10.1093/ofid/ofy210.557","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ofid/ofy210.557","pdf_url":null,"source":{"id":"https://openalex.org/S2735126445","display_name":"Open Forum Infectious Diseases","issn_l":"2328-8957","issn":["2328-8957"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infectious Diseases","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:5239662","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC6255645","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:6255645","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6255645","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infect Dis","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1093/ofid/ofy210.557","doi":"https://doi.org/10.1093/ofid/ofy210.557","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ofid/ofy210.557","pdf_url":null,"source":{"id":"https://openalex.org/S2735126445","display_name":"Open Forum Infectious Diseases","issn_l":"2328-8957","issn":["2328-8957"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infectious Diseases","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2981544240","https://openalex.org/W3160782810","https://openalex.org/W2752004085","https://openalex.org/W2746406130","https://openalex.org/W4404834503","https://openalex.org/W4320475007","https://openalex.org/W2981579599","https://openalex.org/W4297037226","https://openalex.org/W4410922867","https://openalex.org/W4408387771"],"abstract_inverted_index":{"Weight":[0,256,311],"gain":[1,33,312],"in":[2,25,60,81,203,306],"patients":[3,63,84,138,145,158,196,208,218,284],"with":[4,37,64,139,159,285],"HIV":[5,65,162,286],"infection":[6,66],"taking":[7],"antiretroviral":[8],"therapy":[9],"(ART)":[10],"is":[11],"of":[12,19,50,106,194,290],"great":[13],"concern,":[14],"given":[15],"the":[16,42,51,104,169,184,204,234,249],"increased":[17,257,271],"risk":[18],"diabetes":[20],"mellitus":[21],"and":[22,54,58,78,116,155,157,174,180,200,215,241,269],"cardiovascular":[23],"disease":[24],"this":[26],"population.":[27],"Recent":[28],"reports":[29],"suggest":[30],"that":[31,149],"weight":[32,57,77,151,173],"may":[34,313],"be":[35,316],"associated":[36],"a":[38,98,142,212,222,319],"new":[39],"ART":[40,100],"class,":[41],"integrase":[43],"strand":[44],"transfer":[45],"inhibitors":[46],"(INSTIs).":[47],"The":[48,303],"effect":[49],"INSTIs":[52],"elvitegravir":[53],"dolutegravir":[55],"on":[56,97,258,272],"BMI":[59,79,175,270,307],"virologically":[61],"suppressed":[62],"has":[67],"not":[68],"been":[69],"fully":[70],"elucidated.":[71],"This":[72],"retrospective":[73],"observational":[74],"study":[75,170,198],"evaluated":[76],"changes":[80],"aviremic":[82],"HIV-infected":[83],"who":[85,120,146],"switched":[86,121,210,220],"to":[87,122,179,211,221,233,297,315],"an":[88,123,288,298,323],"elvitegravir-":[89,124,299,324],"or":[90,125,141,300,325],"dolutegravir-containing":[91,126,213,301,326],"regimen.":[92,302,327],"Patients":[93],"\u226518":[94],"years":[95],"old":[96],"stable":[99],"regimen":[101,127,214,223],"seen":[102],"at":[103,129],"University":[105],"Utah":[107],"Health":[108],"Infectious":[109],"Diseases":[110],"Clinic":[111],"between":[112],"January":[113],"1,":[114],"2012":[115],"February":[117],"28,":[118],"2017":[119],"for":[128],"least":[130],"1":[131],"year":[132,182],"were":[133,187,201,209,219,227,243],"included.":[134],"Exclusion":[135],"criteria":[136,199],"included":[137,202,317],"hypogonadism":[140],"thyroid":[143],"disorder,":[144],"received":[147],"medications":[148],"impact":[150],"(including":[152],"steroids,":[153],"levothyroxine,":[154],"metformin),":[156],"two":[160],"consecutive":[161],"viral":[163],"load":[164],"values":[165,176],">200":[166],"copies/mL":[167],"during":[168],"period.":[171],"Body":[172],"collected":[177],"prior":[178,232],"~1":[181],"after":[183,295],"switch":[185,235],"date":[186,236],"compared":[188],"using":[189,322],"paired":[190],"t-tests.":[191],"A":[192],"total":[193],"118":[195],"met":[197],"analysis.":[205],"Eighty-eight":[206],"(74.6%)":[207],"30":[216],"(25.4%)":[217],"containing":[224],"elvitegravir.":[225],"Pre-measurements":[226],"taken":[228,244],"5.9":[229],"(\u00b113.3)":[230],"days":[231,247,294],"(range:":[237,252],"\u221283,":[238],"+1":[239],"days),":[240],"post-measurements":[242],"310":[245],"(\u00b156)":[246],"following":[248],"medication":[250],"change":[251],"186,":[253],"399":[254],"days).":[255],"average":[259,273,289,304],"2.3":[260,291],"kg":[261,292],"(95%":[262,276],"CI:":[263,277],"1.6,":[264],"3;":[265],"P":[266,280],"<":[267,281],"0.001),":[268],"0.8":[274,309],"kg/m2":[275],"0.5,":[278],"1;":[279],"0.001).":[282],"Aviremic":[283],"gained":[287],"~310":[293],"switching":[296],"increase":[305],"was":[308],"kg/m2.":[310],"need":[314],"as":[318],"consideration":[320],"when":[321],"All":[328],"authors:":[329],"No":[330],"reported":[331],"disclosures.":[332]},"counts_by_year":[{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1}],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2018-10-05T00:00:00"}